'Sarcobesity': a Metabolic Conundrum
Overview
Affiliations
Two independent but inter-related conditions that have a growing impact on healthy life expectancy and health care costs in developed nations are an age-related loss of muscle mass (i.e., sarcopenia) and obesity. Sarcopenia is commonly exacerbated in overweight and obese individuals. Progression towards obesity promotes an increase in fat mass and a concomitant decrease in muscle mass, producing an unfavourable ratio of fat to muscle. The coexistence of diminished muscle mass and increased fat mass (so-called 'sarcobesity') is ultimately manifested by impaired mobility and/or development of life-style-related diseases. Accordingly, the critical health issue for a large proportion of adults in developed nations is how to lose fat mass while preserving muscle mass. Lifestyle interventions to prevent or treat sarcobesity include energy-restricted diets and exercise. The optimal energy deficit to reduce body mass is controversial. While energy restriction in isolation is an effective short-term strategy for rapid and substantial weight loss, it results in a reduction of both fat and muscle mass and therefore ultimately predisposes one to an unfavourable body composition. Aerobic exercise promotes beneficial changes in whole-body metabolism and reduces fat mass, while resistance exercise preserves lean (muscle) mass. Current evidence strongly supports the inclusion of resistance and aerobic exercise to complement mild energy-restricted high-protein diets for healthy weight loss as a primary intervention for sarcobesity.
Saturated fatty acids negatively affect musculoskeletal tissues and .
Lin R, Osipov B, Steffen D, Chamberlin M, Pathak S, Christiansen B Matrix Biol Plus. 2024; 23:100153.
PMID: 38882396 PMC: 11179588. DOI: 10.1016/j.mbplus.2024.100153.
Association between sarcopenic obesity and knee osteoarthritis: A narrative review.
Balogun S, Scott D, Aitken D Osteoarthr Cartil Open. 2024; 6(3):100489.
PMID: 38832052 PMC: 11145545. DOI: 10.1016/j.ocarto.2024.100489.
Body composition parameters and sarcopenia in adults with Down syndrome: a case-control study.
Villani E, Onder G, Marzetti E, Coelho-Junior H, Calvani R, Di Paola A Aging Clin Exp Res. 2024; 36(1):81.
PMID: 38551714 PMC: 10980647. DOI: 10.1007/s40520-023-02680-9.
Alexander L, Christensen S, Richardson L, Ingersoll A, Burridge K, Golden A Obes Pillars. 2023; 1:100005.
PMID: 38085928 PMC: 10661909. DOI: 10.1016/j.obpill.2021.100005.
Preventing Osteoporosis, Sarcopenia and Obesity to Care about Quality of Life.
Cacciatore S, Massaro C, Landi F Ann Geriatr Med Res. 2023; 27(1):87-90.
PMID: 36846863 PMC: 10073975. DOI: 10.4235/agmr.22.0158.